Recurrent differentiated thyroid carcinoma: Biological implications of age, method of detection, and site and extent of recurrence

Annals of Surgical Oncology

Volumn 9, Issue 8, 2002, Pages 789-798

  Stojadinovic, Alexander ^a   Shoup, Margo ^a   Nissan, Aviram ^a   Ghossein, Ronald A ^a   Shah, Jatin P ^a   Brennan, Murray F ^a   Shaha, Ashok R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Carcinoma; Outcome; Recurrence; Thyroid

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHENOTYPE; PREDICTION; RECURRENT CANCER; REGRESSION ANALYSIS; SURVIVAL RATE; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 0036789831     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2002.02.001     Document Type: Article

References (21)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-48.
2. Rossi RL, Cady B, Silverman ML, Wool MS, Horner TA. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-22.
3. Sanders LE, Silverman M. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. Surgery 1998;124:967-74.
4. Sanders LE, Cady B. Differentiated thyroid cancer. Reexamination of risk groups and outcome of treatment. Arch Surg 1998;133: 419-25.
5. Stojadinovic A, Ghossein RA, Hoos A, et al. Hürthle cell carcinoma: a critical histopathological appraisal. J Clin Oncol 2001;19: 2616-25.
6. Tollefsen HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Recurrence in the gland after initial surgical treatment. Am J Surg 1972;124:468-72.
7. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 1977;56:171-96.
8. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy and outcome. Mayo Clin Proc 1986;61:978-96.
9. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988;104:954-62.
10. 131). Ann Surg 1994;219:587-95.
11. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978;136: 107-12.
12. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991; 162:353-6.
13. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14:315-32.
14. Schlumberger M, Tubiana M, De Vathaire F. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986; 63:960-7.
15. Hamby LS, McGrath PC, Schwartz RW. Management of local recurrence of well-differentiated thyroid carcinoma. J Surg Res 1992;52:113-7.
16. Westbury C, Vini L, Fisher C, Harmer C. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Thyroid 2000;10:171-6.
17. Ashcraft MJ, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up of patients with treated differentiated thyroid cancer. Am J Med 1981;71:806-14.
18. Tyler DS, Shaha AR, Udelsman RA, et al. Thyroid cancer: 1999 update. Ann Surg Oncol 2000;7:376-98.
19. Franceschi M, Kusic Z, Franceschi D, et al. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996;37: 446-51.
20. Frilling A, Gorges R, Tecklenborg K, et al. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 2000;128:1067-74.
21. Grigsby PW, Baglan K, Siegel BA. Surveillance of patients to detect recurrent thyroid carcinoma. Cancer 1999;85:945-51.